Desformylflustrabromine hydrochloride is primarily used in research settings to study its effects on nicotinic acetylcholine receptors. It has shown potential as a modulator of these receptors, making it a valuable tool for understanding neurological pathways and disorders related to acetylcholine signaling. Additionally, it has been investigated for its possible neuroprotective properties, which could have implications in treating neurodegenerative diseases. Researchers also explore its role in modulating inflammatory responses, suggesting potential applications in conditions involving chronic inflammation. Its unique mechanism of action makes it a promising candidate for further pharmacological and therapeutic studies.